Helsinki-based MVision AI has raised $5.9M in post-seed financing led by J12 Ventures and Voima Ventures.
The
startup specializes in cloud-based software for radiotherapy treatment
planning, which it claims reduces the manual work involved in the OAR
contouring process by up to 95%.
- Founded
in 2017, MVision AI offers a cloud-based SaaS solution for radiotherapy
treatment planning equipped with an AI-powered automatic segmentation
tool that standardizes contouring and streamlines the treatment planning
workflow.
- Contouring
is a treatment planning process that outlines targets and organs at
risk to guide radiotherapy plans that optimize tumor control and reduce
radiation toxicity.
- The
solution contains a deep learning model to produce real-time consistent
contouring while ensuring high standards of quality for all patients.
- According to the company website, MVision AI can integrate seamlessly with hospital systems and is also GDPR and HIPAA-compliant.
- A recent press release reveals
that the startup plans to use its fresh funds to develop additional
cancer treatment solutions and build a globally scalable cloud-based
platform for cancer treatment.
